Vicentra BV aims to make its Kaleido 2 insulin patch pump and automated insulin delivery system even smaller than its current device, already amongst the smallest, lightest and most precise insulin ...

Novartis' Fabhalta has become the first treatment approved by the FDA for the ultra-rare kidney disease C3G. But analysts ...

Sweden's Northern Offshore Services (NOS) has entered a new vessel market by snapping up a service operation vessel (SOV) from John Fredriksen-backed Edda Wind. The deal comes a month after its parent ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...

ABB has announced its collaboration with Stadler US to advance sustainable rail transport in the United States (US). The ...

With another inflammatory bowel disease (IBD) approval in the bag for Tremfya, Johnson & Johnson continues to make good on ...

REYKJAVIK, Iceland and STOCKHOLM, Sweden I March 20, 2025 I Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture ...

Private equity firm Hellman & Friedman has selected banks to lead the initial public offering of security group Verisure, ...

Patricia Industries' subsidiary Advanced Instruments has entered into a definitive agreement to acquire Nova Biomedical from its founding shareholders for an enterprise value of USD 2.2bn. Advanced In ...

“The FDA's filing acceptance of Dr. Reddy's proposed denosumab biosimilar marks an important milestone in bringing this biosimilar medication to more patients throughout the U.S.,” said Milan ...

Stada Arzneimittel AG’s private equity owners are pushing back a planned initial public offering of the German drugmaker ...

January 9, 2025 German drug firm Stada lines up new chairman and board ahead of IPO Stada has lined up a new independent chairman and board of directors in a key step for the private equity-backed ...